Items where authors include "Wilson, R"

Article

Calvert, MJ, Cruz Rivera, S, Retzer, A et al. (19 more authors) (2022) Patient reported outcome assessment must be inclusive and equitable. Nature Medicine, 28 (6). pp. 1120-1124. ISSN 1078-8956

Tomic, A, Skelly, DT, Ogbe, A et al. (105 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nature Communications, 13 (1). 1251. ISSN 2041-1723

Ahmed, WUR, Bhatia, S, McLean, KA et al. (4545 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS Open, 6 (1). zrab150. ISSN 2474-9842

Angyal, A, Longet, S, Moore, SC et al. (176 more authors) (2022) T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. The Lancet Microbe, 3 (1). e21-e31. ISSN 2666-5247

Lally, P, Beeken, RJ orcid.org/0000-0001-8287-9351, Wilson, R et al. (7 more authors) (2022) A manualised weight management programme for adults with mild–moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD). Journal of Applied Research in Intellectual Disabilities, 35 (1). pp. 112-122. ISSN 1360-2322

Payne, RP, Longet, S, Austin, JA et al. (132 more authors) (2021) Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell, 184 (23). 5699-5714.e11. ISSN 0092-8674

Skelly, DT, Harding, AC, Gilbert-Jaramillo, J et al. (92 more authors) (2021) Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nature Communications, 12 (1). 5061.

Farías-Barahona, D, Wilson, R, Bravo, C orcid.org/0000-0003-4822-4786 et al. (11 more authors) (2020) A near 90-year record of the evolution of El Morado Glacier and its proglacial lake, Central Chilean Andes. Journal of Glaciology. ISSN 0022-1430

Bottomley, A, Reijneveld, JC, Koller, M et al. (30 more authors) (2019) Current state of quality of life and patient-reported outcomes research. European Journal of Cancer, 121. pp. 55-63. ISSN 0959-8049

Selby, P, Liu, L, Downing, A orcid.org/0000-0002-0335-7801 et al. (10 more authors) (2019) How can clinical research improve European health outcomes in cancer? Journal of Cancer Policy, 20. ARTN 100182. ISSN 2213-5383

Wilson, R orcid.org/0000-0003-2099-5896 (2019) ‘Our late most excellent viceroy’: Irish Responses to the Death of the Duke of Rutland in 1787. Journal for Eighteenth-Century Studies, 42 (1). pp. 67-83. ISSN 1754-0194

Clarke, EL, Revie, C, Brettle, D et al. (6 more authors) (2018) Development of a novel tissue-mimicking color calibration slide for digital microscopy. Color Research and Application, 43 (2). pp. 184-197. ISSN 0361-2317

Adams, R, Brown, E, Brown, L et al. (14 more authors) (2018) Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial. Lancet Gastroenterology and Hepatology, 3 (3). pp. 162-171. ISSN 2468-1253

Shoemark, A, Moya, E, Hirst, RA et al. (34 more authors) (2018) High prevalence of CCDC103 p.His154Pro mutation causing primary ciliary dyskinesia disrupts protein oligomerisation and is associated with normal diagnostic investigations. Thorax, 73 (2). pp. 157-166. ISSN 0040-6376

Bierma-Zeinstra, SMA, Brew, J, Stoner, K et al. (3 more authors) (2017) A New Lipid Formulation Of Low Dose Ibuprofen Shows Non-Inferiority To High Dose Standard Ibuprofen: The Flare Study (Flaring Arthralgia Relief Evaluation In Episodic Flaring Knee Pain) - A Randomised Double-Blind Study. Osteoarthritis and Cartilage, 25 (12). pp. 1942-1951. ISSN 1063-4584

Beeken, RJ orcid.org/0000-0001-8287-9351, Croker, H, Heinrich, M et al. (10 more authors) (2017) The Impact of Diet-Induced Weight Loss on Biomarkers for Colorectal Cancer: An Exploratory Study (INTERCEPT). Obesity, 25 (S2). S95-S101. ISSN 1930-7381

Ridings-Figueroa, R, Stewart, ER, Nesterova, TB et al. (14 more authors) (2017) The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes and Development, 31 (9). pp. 876-888. ISSN 0890-9369

Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836

Beeken, RJ orcid.org/0000-0001-8287-9351, Leurent, B, Vickerstaff, V et al. (6 more authors) (2017) A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial. International Journal of Obesity, 41 (2). pp. 246-254. ISSN 0307-0565

Lawler, M, Banks, I, Law, K et al. (57 more authors) (2017) The European Cancer Patient’s Bill of Rights, update and implementation 2016. ESMO Open, 2016 (1). e000127. ISSN 2059-7029

Bogaerts, J, Sydes, MR, Keat, N et al. (43 more authors) (2014) Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. European journal of cancer. ISSN 0014-2964

Wilson, R, Goodacre, SW, Klingbajl, M et al. (6 more authors) (2013) Evaluation of the DAVROS (Development And Validation of Risk-adjusted Outcomes for Systems of emergency care) risk-adjustment model as a quality indicator for healthcare. Emergency Medicine Journal. ISSN 1472-0205

Owens, OJ, Taggart, C, Wilson, R et al. (3 more authors) (1993) Interleukin-2 receptor and ovarian cancer. British Journal of Cancer, 68 (2). pp. 364-367. ISSN 1532-1827

Conference or Workshop Item

Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L, Woroncow, B et al. (5 more authors) (2022) eRAPID: INSIGHTS UnderstandIng, iNterpreting and SharInG patient reported data: Further in-deptH analysis and visualisaTion of cancer Symptom profiles from the eRAPID programme. In: British Psychosocial Oncology Society 2022 Conference, Equality, Diversity and Inclusion in Psychosocial Oncology, 28-29 Apr 2022, Online.

Proceedings Paper

Calvert, MJ, Rivera, SC, Retzer, A et al. (19 more authors) (2022) Patient reported outcome assessment must be inclusive and equitable. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czechia. Springer , S117-S118.

Richman, SD orcid.org/0000-0003-3993-5041, Adams, R, Brown, E et al. (14 more authors) (2017) FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, bRAF and PIK3CA. In: Journal of Pathology. Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 Jun 2017, Belfast, Northern Ireland, UK. Wiley , S13-S13.

Adams, RA, Brown, E, Brown, L et al. (13 more authors) (2016) FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS & NRAS. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen. Oxford University Publishing .